Barely Significant
← all excerpts

<i>BCL11B</i> Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia.

Clin Med Insights Oncol · 2023 · PMC10697049 · PMID 38058602

Europe PMCDOI
1
hedged sentence
0.0680
closest p · 1.4× alpha
0.0680
boldest claim

The sentences

a clear trendP = .068so close (0.05 < p ≤ 0.1)
Interestingly, there was a clear trend suggesting that patients with T-ALL harboring a BCL11B mutation had a higher percentage of CR ( P = .068) and negative MRD ( P = .050), although the data were not yet statistically significant at this point ( Figure 1B ).

also in 5,860 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.